| PRL |
PRL: Prolactin precursor |
GHR |
GHR: Growth hormone receptor precursor |
0.557 |
Evidence |
|
| TIMP1 |
TIMP1, CLGI, TIMP: Metalloproteinase inhibitor 1 precursor |
KEL |
KEL: Kell blood group glycoprotein |
0.557 |
Evidence |
|
| AGT |
AGT, SERPINA8: Angiotensinogen precursor |
ST14 |
ST14, PRSS14, SNC19, TADG15: Suppressor of tumorigenicity protein 14 |
0.557 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.557 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.557 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.557 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
0.557 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
0.557 |
Evidence |
|
| F8 |
F8, F8C: Coagulation factor VIII precursor |
EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
0.557 |
Evidence |
|
| CP |
CP: Ceruloplasmin precursor |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
0.557 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.557 |
Evidence |
|
| TLR2 |
TLR2, TIL4: Toll-like receptor 2 precursor |
IL1A |
IL1A, IL1F1: Interleukin-1 alpha precursor |
0.557 |
Evidence |
|
| OR10H3 |
OR10H3: Olfactory receptor 10H3 |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.557 |
Evidence |
|
| OR10H3 |
OR10H3: Olfactory receptor 10H3 |
PF4 |
PF4, CXCL4, SCYB4: Platelet factor 4 precursor |
0.557 |
Evidence |
|
| PCDH7 |
PCDH7, BHPCDH: Protocadherin-7 precursor |
JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
0.557 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
MET |
MET: Hepatocyte growth factor receptor precursor |
0.557 |
Evidence |
|
| RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
0.557 |
Evidence |
O
|
| RGS16 |
RGS16, RGSR: Regulator of G-protein signaling 16 |
GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
0.557 |
Evidence |
|
| TMPRSS2 |
TMPRSS2, PRSS10: Transmembrane protease, serine 2 precursor |
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
0.557 |
Evidence |
|
| TMPRSS2 |
TMPRSS2, PRSS10: Transmembrane protease, serine 2 precursor |
AGT |
AGT, SERPINA8: Angiotensinogen precursor |
0.557 |
Evidence |
|
| ADAMDEC1 |
ADAMDEC1: ADAM DEC1 precursor |
TIMP1 |
TIMP1, CLGI, TIMP: Metalloproteinase inhibitor 1 precursor |
0.557 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
TSHR |
IPI00386365 |
0.557 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
0.557 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
0.557 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
0.557 |
Evidence |
|